Utime Addresses Recent Stock Plunge, Emphasizing Transparency and Medical Expansion

Utime, a leading provider of affordable mobile devices, has addressed concerns regarding recent fluctuations in its stock price. The company acknowledges the market’s anxieties and stresses its dedication to transparency and investor protection. Utime assures investors that its operations are functioning normally and that no events have negatively impacted the company’s fundamentals. Furthermore, Utime highlights its recent entry into the medical industry, partnering with renowned medical experts and institutions to develop an MPOX vaccine. This expansion reflects Utime’s commitment to innovation and diversification.